VON EULER CONSULTING - Key Persons

Mikael von Euler MD PhD FFPM is an Oncologist, trained at Karoliska Institute in Stockholm, Sweden with more than 30 years of experience of Oncology, both as a clinician and from the Pharmaceutical Industry. He has held senior positions in Big Pharma companies at AstraZeneca, GSK and Roche as well as in start up biotech as CMO and Head of R&D at Oncos Ltd. He has made major contributions to the development of Nolvadex, Arimidex, Zoladex, Faslodex, Iressa, Tykerb, Votrient, Revolade, Herceptin, pertuzumab and T-DM1. He is currently acting CEO of KDev Oncology AB, a Karolinska Development Company, Axelar AB and Akinion Pharmaceuticals AB as well as CMO of Aprea AB.